Business
Encoded Raises $275M to Push a One-Time Gene Therapy for a Severe Childhood Epilepsy
Interim trial data showed up to 79% fewer monthly seizures after a single dose — and now Encoded Therapeutics has fresh funding to drive its Dravet syndrome gene therapy toward pivotal trials.